{"transactions":[{"id":737665,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:13:36.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":7.1967,"value":194310.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 03-12-2025"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001437749-26-020706","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020706/rdgdoc.xml","form_type":"4"}},{"id":737664,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:13:36.000Z","date":"2026-06-11","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001437749-26-020706","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020706/rdgdoc.xml","form_type":"4"}},{"id":1107818,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T23:49:43.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":3.4,"value":91800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03/12/2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001437749-25-020717","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020717/rdgdoc.xml","form_type":"4"}},{"id":1111410,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:18:03.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001437749-25-020362","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020362/rdgdoc.xml","form_type":"4"}},{"id":1471917,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:22:50.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001437749-24-021020","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021020/rdgdoc.xml","form_type":"4"}},{"id":1477154,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-17T23:23:24.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":3.3266,"value":89818.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2801 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-24-020570","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924020570/rdgdoc.xml","form_type":"4"}},{"id":1854151,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-16T01:03:59.000Z","date":"2023-06-13","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001437749-23-017606","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923017606/rdgdoc.xml","form_type":"4"}},{"id":1854150,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-16T01:03:59.000Z","date":"2023-06-13","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":3.4548,"value":93279.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.42 to $3.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-23-017606","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923017606/rdgdoc.xml","form_type":"4"}},{"id":2225266,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-22T01:55:01.000Z","date":"2022-06-16","kind":"sale","acquired":false,"shares":27858,"price":2.6313,"value":73302.7554,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.554 to $2.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001437749-22-015538","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922015538/rdgdoc.xml","form_type":"4"}},{"id":2227457,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-17T20:26:56.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":54858,"source":{"system":"sec-edgar","filing":"0001437749-22-015296","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922015296/rdgdoc.xml","form_type":"4"}},{"id":2663417,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-18T00:35:26.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":27858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":27858,"source":{"system":"sec-edgar","filing":"0001209191-21-041781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121041781/doc4.xml","form_type":"4"}},{"id":2668101,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-15T22:14:17.000Z","date":"2021-06-11","kind":"sale","acquired":false,"shares":40993,"price":11.1667,"value":457756.5331,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.08 to $11.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-040710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121040710/doc4.xml","form_type":"4"}},{"id":3110420,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-06-15T20:34:33.000Z","date":"2020-06-11","kind":"sale","acquired":false,"shares":10000,"price":9.8878,"value":98878.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $9.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":40993,"source":{"system":"sec-edgar","filing":"0001209191-20-036622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120036622/doc4.xml","form_type":"4"}},{"id":3113228,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-06-12T00:08:00.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":25748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":50993,"source":{"system":"sec-edgar","filing":"0001209191-20-036126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120036126/doc4.xml","form_type":"4"}},{"id":3150728,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-13T18:30:12.000Z","date":"2020-05-12","kind":"exercise","acquired":false,"shares":9357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on July 11, 2017, and has vested as to 25% of the shares underlying the option as of July 10, 2018 with the remainder vesting quarterly through July 10, 2021."}],"balance_after":99663,"derivative":{"exercise_price":5.51,"expiration_date":"2027-07-10","underlying":"Common Stock","underlying_shares":9357},"source":{"system":"sec-edgar","filing":"0001562180-20-003589","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000156218020003589/primarydocument.xml","form_type":"4"}},{"id":3150727,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-13T18:30:12.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":9357,"price":50.1751,"value":469488.4107,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15884,"source":{"system":"sec-edgar","filing":"0001562180-20-003589","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000156218020003589/primarydocument.xml","form_type":"4"}},{"id":3150726,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-13T18:30:12.000Z","date":"2020-05-12","kind":"exercise","acquired":true,"shares":9357,"price":5.51,"value":51557.07,"ownership":{"direct":true},"balance_after":25241,"source":{"system":"sec-edgar","filing":"0001562180-20-003589","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000156218020003589/primarydocument.xml","form_type":"4"}},{"id":3266697,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-18T16:54:35.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 14, 2020, and the shares underlying the option vest in equal quarterly installments through February 14, 2024, subject to continued service."}],"balance_after":50000,"derivative":{"exercise_price":36.06,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-20-004899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924320004899/doc4.xml","form_type":"4"}},{"id":3376394,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-08T17:28:54.000Z","date":"2019-11-06","kind":"exercise","acquired":false,"shares":27232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on July 11, 2017, and has vested as to 25% of the shares underlying the option as of July 10, 2018 with the remainder vesting quarterly through July 10, 2021."}],"balance_after":109020,"derivative":{"exercise_price":5.51,"expiration_date":"2027-07-10","underlying":"Common Stock","underlying_shares":27232},"source":{"system":"sec-edgar","filing":"0001562180-19-005422","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/primarydocument.xml","form_type":"4"}},{"id":3376393,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-08T17:28:54.000Z","date":"2019-11-06","kind":"sale","acquired":false,"shares":5451,"price":35.1118,"value":191394.4218,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $35.00 to $35.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15884,"source":{"system":"sec-edgar","filing":"0001562180-19-005422","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/primarydocument.xml","form_type":"4"}},{"id":3376392,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-08T17:28:54.000Z","date":"2019-11-06","kind":"sale","acquired":false,"shares":10899,"price":30.1437,"value":328536.1863,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21335,"source":{"system":"sec-edgar","filing":"0001562180-19-005422","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/primarydocument.xml","form_type":"4"}},{"id":3376391,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-08T17:28:54.000Z","date":"2019-11-06","kind":"sale","acquired":false,"shares":5451,"price":25.1799,"value":137255.6349,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $25.00 to $25.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":32234,"source":{"system":"sec-edgar","filing":"0001562180-19-005422","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/primarydocument.xml","form_type":"4"}},{"id":3376390,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-08T17:28:54.000Z","date":"2019-11-06","kind":"sale","acquired":false,"shares":5431,"price":20.0078,"value":108662.3618,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.00 to $20.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":37685,"source":{"system":"sec-edgar","filing":"0001562180-19-005422","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/primarydocument.xml","form_type":"4"}},{"id":3376389,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-08T17:28:54.000Z","date":"2019-11-06","kind":"exercise","acquired":true,"shares":27232,"price":5.51,"value":150048.32,"ownership":{"direct":true},"balance_after":43116,"source":{"system":"sec-edgar","filing":"0001562180-19-005422","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/primarydocument.xml","form_type":"4"}},{"id":3492570,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2019-06-13T00:49:02.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":19423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":25245,"source":{"system":"sec-edgar","filing":"0001209191-19-036576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119036576/doc4.xml","form_type":"4"}},{"id":3604016,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-08T16:54:37.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 7, 2019, and the shares underlying the option vest in equal quarterly installments through March 7, 2023, subject to continued service."}],"balance_after":93000,"derivative":{"exercise_price":8.76,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0000899243-19-006926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924319006926/doc4.xml","form_type":"4"}},{"id":3729017,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-17T16:46:29.000Z","date":"2018-12-13","kind":"exercise","acquired":false,"shares":6801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on July 11, 2017, and is schedule to vest (i) as to 9,083 shares underlying the option in equal quarterly installments from July 10, 2017 through July 10, 2021 and (ii) as to 63,584 shares underlying the option in equal quarterly installments from July 19, 2018 through July 19, 2022."}],"balance_after":65866,"derivative":{"exercise_price":5.51,"expiration_date":"2027-07-10","underlying":"Common Stock","underlying_shares":6801},"source":{"system":"sec-edgar","filing":"0000899243-18-031227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318031227/doc4.xml","form_type":"4"}},{"id":3729016,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-17T16:46:29.000Z","date":"2018-12-13","kind":"exercise","acquired":false,"shares":9083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 11, 2017, and has vested as to 25% of the shares underlying the option as of July 10, 2018 with the remainder vesting quarterly through July 10, 2021."}],"balance_after":136252,"derivative":{"exercise_price":5.51,"expiration_date":"2027-07-10","underlying":"Common Stock","underlying_shares":9083},"source":{"system":"sec-edgar","filing":"0000899243-18-031227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318031227/doc4.xml","form_type":"4"}},{"id":3729015,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-17T16:46:29.000Z","date":"2018-12-13","kind":"exercise","acquired":true,"shares":6801,"price":5.51,"value":37473.51,"ownership":{"direct":true},"balance_after":15884,"source":{"system":"sec-edgar","filing":"0000899243-18-031227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318031227/doc4.xml","form_type":"4"}},{"id":3729014,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-17T16:46:29.000Z","date":"2018-12-13","kind":"exercise","acquired":true,"shares":9083,"price":5.51,"value":50047.33,"ownership":{"direct":true},"balance_after":9083,"source":{"system":"sec-edgar","filing":"0000899243-18-031227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318031227/doc4.xml","form_type":"4"}},{"id":3863624,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-20T17:40:07.000Z","date":"2018-07-19","kind":"grant","acquired":true,"shares":19075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 19, 2018 and is scheduled to vest in equal quarterly installments through July 19, 2022, subject to continued service."}],"balance_after":19075,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":19075},"source":{"system":"sec-edgar","filing":"0000899243-18-020281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318020281/doc4.xml","form_type":"4"}},{"id":3893663,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-06-14T23:16:37.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":5822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":5822,"source":{"system":"sec-edgar","filing":"0001209191-18-037883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118037883/doc4.xml","form_type":"4"}},{"id":4282137,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-15T01:19:56.000Z","date":"2017-06-12","kind":"grant","acquired":true,"shares":7604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":7604,"derivative":{"exercise_price":79.2,"expiration_date":"2027-06-11","underlying":"Common Stock","underlying_shares":7604},"source":{"system":"sec-edgar","filing":"0001209191-17-040003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117040003/doc4.xml","form_type":"4"}},{"id":4495057,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-09T22:17:33.000Z","date":"2017-01-05","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 5, 2017. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of January 1, 2017 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until January 1, 2019."}],"balance_after":150000,"derivative":{"exercise_price":0.82,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-17-002984","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117002984/doc4.xml","form_type":"4"}},{"id":4495056,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-09T22:17:33.000Z","date":"2017-01-05","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 5, 2017. The shares underlying the option are scheduled to vest in equal monthly installments over four years from January 1, 2017."}],"balance_after":60000,"derivative":{"exercise_price":0.82,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-17-002984","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117002984/doc4.xml","form_type":"4"}},{"id":4552743,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-16T22:49:38.000Z","date":"2016-11-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting commencement date (\"VCD\") of the option is November 14, 2016. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the VCD and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the VCD thereafter, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":40.1,"expiration_date":"2026-11-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-16-150634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919116150634/doc4.xml","form_type":"4"}}]}